...
首页> 外文期刊>Drug discovery today >Hsp90: the vulnerable chaperone.
【24h】

Hsp90: the vulnerable chaperone.

机译:Hsp90:易受攻击的伴侣。

获取原文
获取原文并翻译 | 示例
           

摘要

The molecular chaperone Hsp90 has emerged as an important target in cancer treatment because of its roles in maintaining transformation and regulating the function of proteins involved in apoptotic, survival and growth pathways. Many Hsp90 inhibitors function by binding to the N-terminal ATP pocket, but the chaperone has many other vulnerable points. Agents that interact with its C-terminus or modify its post-translational status represent additional ways of interfering with chaperone activity. This review will discuss several emerging classes of Hsp90 inhibitors and their modes of action.
机译:分子伴侣蛋白Hsp90已经成为癌症治疗中的重要靶标,因为它在维持转化和调节凋亡,存活和生长途径中涉及的蛋白质功能中的作用。许多Hsp90抑制剂通过与N末端ATP口袋结合而起作用,但该伴侣分子还有许多其他脆弱点。与C末端相互作用或修饰其翻译后状态的试剂代表了干扰伴侣活性的其他方法。这篇综述将讨论Hsp90抑制剂的几种新兴类别及其作用方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号